1 Scope
This International Standard defines a set of models collectively referred to as the
Biomedical Research Integrated Domain Group (BRIDG) model for use in supporting development
of computer software, databases, metadata repositories, and data interchange standards.
It supports technology solutions that enable semantic (meaning-based) interoperability
within the biomedical/clinical research arena and between research and the healthcare
arena. The clinical research semantics are represented as a set of visual diagrams
which describe information relationships, definitions, explanations, and examples
used in protocol-driven biomedical research. These diagrams are expressed using the
iconography and grammar of the Unified Modelling Language (UML), the HL7 Reference Information Model (RIM), and a Web Ontology Language (OWL).
This International Standard establishes the links between protocol-driven research
and its associated regulatory artefacts including the data, organization, resources,
rules, and processes involved in the formal assessment of the utility, impact, or
other pharmacological, physiological, or psychological effects of a drug, procedure,
process, subject characteristic, or device on a human, animal, or other subject or
substance along with all associated regulatory artefacts required for or derived from
this effort, including data specifically associated with post-marketing adverse event reporting.